20
Cadila Healthcare Limited Ankleshwar In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Candesartan cilexetil, Process II, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2012-130 - Rev 01
This Chemical Type CEP, issued on October 03, 2019, remains in force until August 25, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 2573 associated with this CEP further emphasizes